|
|
Blood, 15 May 2004, Vol. 103, No. 10, pp. 3736-3743.
Prepublished online as a Blood First Edition Paper on January 15, 2004; DOI 10.1182/blood-2003-10-3566.
 Previous Article | Table of Contents | Next Article 
HEMATOPOIESIS
Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors
Brian J. Lannutti, and
Jonathan G. Drachman
From the Puget Sound Blood Center, Seattle, WA; and Division of Hematology, University of Washington Medical Center, Seattle.
In this study we demonstrate that thrombopoietin (TPO)–stimulated Src family kinases (SFKs) inhibit cellular proliferation and megakaryocyte differentiation. Using the Src kinase inhibitors pyrolopyrimidine 1 and 2 (PP1, PP2), we show that TPO-dependent proliferation of BaF3/Mpl cells was enhanced at concentrations that are specific for SFKs. Similarly, proliferation is increased after introducing a dominant-negative form of Lyn into BaF3/Mpl cells. Murine marrow cells from Lyn-deficient mice or wild-type mice cultured in the presence of the Src inhibitor, PP1, yielded a greater number of mature megakaryocytes and increased nuclear ploidy. Truncation and targeted mutation of the Mpl cytoplasmic domain indicate that Y112 is critical for Lyn activation. Examining the molecular mechanism for this antiproliferative effect, we determined that SFK inhibitors did not affect tyrosine phosphorylation of Janus kinase 2 (JAK2), Shc, signal transducer and activator of transcription (STAT)5, or STAT3. In contrast, pretreatment of cells with PP2 increased Erk1/2 (mitogen-activated protein kinase [MAPK]) phosphorylation and in vitro kinase activity, particularly after prolonged TPO stimulation. Taken together, our results show that Mpl stimulation results in the activation of Lyn kinase, which appears to limit the proliferative response through a signaling cascade that regulates MAPK activity. These data suggest that SFKs modify the rate of TPO-induced proliferation and are likely to affect cell cycle regulation during megakaryocytopoiesis.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
I. S. Hitchcock, N. E. Fox, N. Prevost, K. Sear, S. J. Shattil, and K. Kaushansky
Roles of focal adhesion kinase (FAK) in megakaryopoiesis and platelet function: studies using a megakaryocyte lineage specific FAK knockout
Blood,
January 15, 2008;
111(2):
596 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. H. Mermel, M. L. McLemore, F. Liu, S. Pereira, J. Woloszynek, C. A. Lowell, and D. C. Link
Src family kinases are important negative regulators of G-CSF-dependent granulopoiesis
Blood,
October 15, 2006;
108(8):
2562 - 2568.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Zhao, D. He, B. Saatian, T. Watkins, E. Wm. Spannhake, N. J. Pyne, and V. Natarajan
Regulation of Lysophosphatidic Acid-induced Epidermal Growth Factor Receptor Transactivation and Interleukin-8 Secretion in Human Bronchial Epithelial Cells by Protein Kinase C{delta}, Lyn Kinase, and Matrix Metalloproteinases
J. Biol. Chem.,
July 14, 2006;
281(28):
19501 - 19511.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Pertel, D. Zhu, R. A. Panettieri, N. Yamaguchi, C. W. Emala, and C. A. Hirshman
Expression and muscarinic receptor coupling of Lyn kinase in cultured human airway smooth muscle cells
Am J Physiol Lung Cell Mol Physiol,
March 1, 2006;
290(3):
L492 - L500.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Lannutti, N. Blake, M. J. Gandhi, J. A. Reems, and J. G. Drachman
Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656
Blood,
May 15, 2005;
105(10):
3875 - 3878.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. L. Drayer, A.-K. Boer, E. L. Los, M. T. Esselink, and E. Vellenga
Stem Cell Factor Synergistically Enhances Thrombopoietin-Induced STAT5 Signaling in Megakaryocyte Progenitors through JAK2 and Src Kinase
Stem Cells,
February 1, 2005;
23(2):
240 - 251.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
